Wachtell Reps Eli Lilly In $1.6B Deal For Oncology Drug Co.
Eli Lilly and Co. on Thursday said it would buy Silicon Valley-based cancer treatment developer Armo BioSciences in a $1.6 billion deal guided by Wachtell Lipton Rosen & Katz, adding to...To view the full article, register now.
Already a subscriber? Click here to view full article